A multicenter, randomized, open label, single and multiple dose study of the pharmacokinetics and pharmacodynamics of 2 dose levels of pantoprazole sodium enteric-coated spheroid suspension in infants aged 1 through 11 months with presumed GERD

Trial Profile

A multicenter, randomized, open label, single and multiple dose study of the pharmacokinetics and pharmacodynamics of 2 dose levels of pantoprazole sodium enteric-coated spheroid suspension in infants aged 1 through 11 months with presumed GERD

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2016

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 01 Aug 2011 Results published in Clinical Pharmacokinetics.
    • 03 Oct 2008 Results were published at the 73rd Annual Scientific Meeting of the American College of Gastroenterology in October 2008.
    • 22 Jul 2008 Status changed from recruiting to completed, as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top